Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients Ruchika Sharma11 April 2025 12:30 PM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...
Biocon Biologics gets USFDA nod for cancer drug Jobevne Ruchika Sharma10 April 2025 12:39 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has...
Biocon to raise up to Rs 600 crore Ruchika Sharma7 April 2025 4:15 PM ISTBangalore: In a recent BSE filing, Biocon has said that its Board of Directors has approved to raise up to Rs 600 crore in one or...
Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension Ruchika Sharma24 March 2025 11:30 AM ISTBengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval from the...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Biocon launches Liraglutide for diabetes, obesity in UK Ruchika Sharma28 Feb 2025 8:26 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for...
Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for Ulcerative Colitis Ruchika Sharma7 Feb 2025 11:30 AM ISTBengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global biopharmaceutical company, have...
Biocon likely to list key biosimilars business by March 2026 Ruchika Sharma1 Feb 2025 2:30 PM ISTHyderabad: Biopharma major Biocon plans to introduce five new biosimilars in the United States in the new fiscal year, starting in April and is likely...
Exempt cancer, rare-disease drugs from tax in budget: Biocon Chief urges govt Ruchika Sharma20 Jan 2025 1:06 PM ISTKiran Mazumdar-Shaw, Chairperson of Biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and rare...
Biocon Biologics to present at 43rd Annual JP Morgan Healthcare Conference Ruchika Sharma10 Jan 2025 1:30 PM ISTKarnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, will present at the 43rd Annual J.P....
Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS Ruchika Sharma7 Jan 2025 1:15 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...
USFDA issues EIR for Biocon Bengaluru facility Ruchika Sharma25 Dec 2024 12:53 PM ISTBengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and...
